Prasad G. Iyer, M.D.
The research program of Prasad G. Iyer, M.D., is focused on identifying the most acceptable noninvasive and accurate techniques for the early detection of esophageal neoplasia (precancerous conditions and early cancer) arising in Barrett's esophagus, which is a complication of gastroesophageal reflux, in the population.
Dr. Iyer and his team are studying biomarkers that can help in the early detection and risk assessment of subjects with Barrett's esophagus. His research program is also studying the role of obesity in the development and progression of neoplasia in subjects with Barrett's esophagus.
Dr. Iyer's research program is currently funded by the National Institutes of Health (National Institute of Diabetes and Digestive and Kidney Diseases and National Cancer Institute), the American College of Gastroenterology and Mayo Clinic.
Significance to patient care
Esophageal adenocarcinoma is a lethal cancer with rapidly rising incidence. Barrett's esophagus and obesity are strong risk factors for this cancer. Endoscopic therapy of Barrett's-related neoplasia has been shown to reduce the incidence of esophageal adenocarcinoma.
Research by Dr. Iyer and his colleagues will hopefully improve the outcomes of patients with this lethal malignancy by developing methods to detect disease early, understand how obesity increases cancer risk, and also treat esophageal cancer detected at an early stage by noninvasive, safe endoscopic techniques.
Clinical and Translational Science Master's Degree Program
Gastroenterology and Hepatology
Internal Medicine (Sinai Samaritan Medical Center)
© 2013 Mayo Foundation for Medical Education and Research. All rights reserved.